Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

CDC-Authored Genomics and Precision Health Publications Database|Home|PHGKB

CDC-Authored Genomics and Precision Health Publications Database


Last data update: May 20, 2022. (Total: 3839 publications since 2011)
   dataset
Filtered By:
Records 1-8 (of 8 Records)
Query Trace: all>>Beverly Metchock[CDC Author]
Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates.
Koné Kaniga, Rumina Hasan, Ruwen Jou, Edita Vasiliauskiene, Charoen Chuchottaworn, Nazir Ismail, Beverly Metchock, Skaidrius Miliauskas, Nguyen Viet Nhung, Camilla Rodrigues, Soyoun Shin, Hulya Simsek, Saijai Smithtikarn, Anh Le Thi Ngoc, Jirakan Boonyasopun, Mubin Kazi, Seungmo Kim, Phalin Kamolwat, Greta Musteikiene, Catherine Ann Sacopon, Sabira Tahseen, Laima Vasiliauskaite, Mei-Hua Wu, and Shaheed Vally Omar
Journal of clinical microbiology 2021 60(1) e0291920
Towards Unified Data Exchange Formats for Reporting Molecular Drug Susceptibility Testing.
Wilfred Bonney, Sandy F Price, , Swapna Abhyankar, Riki Merrick, Varsha Hampole, Tanya A Halse, Charles DiDonato, Tracy Dalton, Beverly Metchock, Angela M Starks, and Roque Miramontes
Online journal of public health informatics 2020 12(2) e14
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Justin L Kandler, Alexandra D Mercante, Tracy L Dalton, Matthew N Ezewudo, Lauren S Cowan, Scott P Burns, Beverly Metchock, , Peter Cegielski, and James E Posey
Antimicrobial agents and chemotherapy 2018 Aug
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison McAlister, David Sikes, Denise Hartline, Beverly Metchock, and Angela M Starks
Tuberculosis research and treatment 2016 3404860
DNA sequencing for confirmation of rifampin resistance detected by Cepheid Xpert MTB/RIF assay.
Allison J McAlister, Jeffrey Driscoll, and Beverly Metchock
J. Clin. Microbiol. 2015 May 53(5) 1752-3
Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States.
Mitchell A Yakrus, Jeffrey Driscoll, Allison J Lentz, David Sikes, Denise Hartline, Beverly Metchock, and Angela M Starks
J. Clin. Microbiol. 2014 Jun 52(6) 1932-7
Evaluation of a u.s. Public health laboratory service for the molecular detection of drug resistant tuberculosis.
Mitchell A Yakrus, Beverly Metchock, and Angela M Starks
Tuberc Res Treat 2015 701786
TOP